As of close of business last night, Xylem Inc.’s stock clocked out at $98.89, down -2.15% from its previous closing price of $101.06. In other words, the price has decreased by -$2.17 from its previous closing price. On the day, 20226866 shares were traded.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Ratios:
To gain a deeper understanding of XYL’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 77.92. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 13 when Decker Patrick sold 56,298 shares for $98.19 per share. The transaction valued at 5,527,837 led to the insider holds 287,564 shares of the business.
Yarkadas Hayati sold 15,942 shares of XYL for $1,601,009 on Mar 02. The SVP & President, EU, WI & GLS now owns 12,146 shares after completing the transaction at $100.43 per share. On Feb 15, another insider, Yarkadas Hayati, who serves as the Senior Vice President of the company, sold 2,083 shares for $106.94 each. As a result, the insider received 222,756 and left with 7,473 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XYL now has a Market Capitalization of 19.21B and an Enterprise Value of 20.21B. As of this moment, Xylem’s Price-to-Earnings (P/E) ratio for their current fiscal year is 48.15, and their Forward P/E ratio for the next fiscal year is 26.27. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.12 while its Price-to-Book (P/B) ratio in mrq is 4.99. Its current Enterprise Value per Revenue stands at 3.55 whereas that against EBITDA is 26.88.
Stock Price History:
Over the past 52 weeks, XYL has reached a high of $118.58, while it has fallen to a 52-week low of $72.08. The 50-Day Moving Average of the stock is 102.77, while the 200-Day Moving Average is calculated to be 102.73.
Shares Statistics:
It appears that XYL traded 1.72M shares on average per day over the past three months and 4.61M shares per day over the past ten days. A total of 180.40M shares are outstanding, with a floating share count of 178.75M. Insiders hold about 0.10% of the company’s shares, while institutions hold 91.70% stake in the company. Shares short for XYL as of Apr 27, 2023 were 13.77M with a Short Ratio of 15.43M, compared to 12.19M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.62% and a Short% of Float of 9.99%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.23, XYL has a forward annual dividend rate of 1.32. Against a Trailing Annual Dividend Yield of 1.22%, it implies a Forward Annual Dividend Yield of 1.27%. The stock’s 5-year Average Dividend Yield is 1.16.
Earnings Estimates
As of right now, 10 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.82 for the current quarter, with a high estimate of $0.87 and a low estimate of $0.79, while EPS last year was $0.66. The consensus estimate for the next quarter is $0.84, with high estimates of $0.88 and low estimates of $0.81.
Analysts are recommending an EPS of between $3.45 and $3.25 for the fiscal current year, implying an average EPS of $3.33. EPS for the following year is $3.76, with 11 analysts recommending between $3.86 and $3.65.
Revenue Estimates
In the current quarter, 9 analysts expect revenue to total $1.5B. It ranges from a high estimate of $1.52B to a low estimate of $1.48B. As of the current estimate, Xylem Inc.’s year-ago sales were $1.36B, an estimated increase of 9.90% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $1.48B, an increase of 7.10% less than the figure of $9.90% in the same quarter last year. There is a high estimate of $1.53B for the next quarter, whereas the lowest estimate is $1.43B.
A total of 11 analysts have provided revenue estimates for XYL’s current fiscal year. The highest revenue estimate was $6.08B, while the lowest revenue estimate was $5.88B, resulting in an average revenue estimate of $5.98B. In the same quarter a year ago, actual revenue was $5.52B, up 8.40% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $6.3B in the next fiscal year. The high estimate is $6.42B and the low estimate is $6.1B. The average revenue growth estimate for next year is up 5.20% from the average revenue estimate for this year.
